The mutation rate of human immunodeficiency virus type 1 is influenced by the vpr gene

Virology

Volumn 222, Issue 2, 1996, Pages 391-400

  Mansky, Louis M ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOPRECIPITATION; MUTATION RATE; PRIORITY JOURNAL; VIRUS GENE; VIRUS MUTATION; VIRUS REPLICATION;

EID: 0030586737     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1996.0436     Document Type: Article

References (74)

1. Alizon, M., Wain-Hobson, S., Montangnier, L., and Sonigo, P. (1986). Genetic variability of the AIDS virus: Nucleotide sequence analysis of two isolates from African patients. Cell 46, 63-74.
2. Balfe, P., Simmonds, P., Ludlam, C. A., Bishop, J. O., and Brown, A. J. L. (1990). Concurrent evolution of human immunodeficiency virus type 1 in patients infected from the same source: Rate of sequence change and low frequency of inactivating mutations. J. Virol. 64, 6221-6233.
3. Baltimore, D. (1970). RNA-dependent DNA polymerase in virions of RNA tumor viruses. Nature (London) 226, 1209-1211.
4. Bebenek, K., Abbotts, J., Roberts, J. D., Wilson, S. H., and Kunkel, T. A. (1989). Specificity and mechanism of error-prone replication by human immunodeficiency virus-1 reverse transcriptase. J. Biol. Chem. 264, 16948-16956.
5. Bebenek, K., Roberts, J. D., and Kunkel, T. A. (1992). The effects of dNTP pool imbalances on frameshift fidelity during DNA replication. J. Biol. Chem. 267, 3589-3596.
6. Bouhamdan, M., Benichou, S., Rey, F., Navarro, J.-M., Agostini, I., Spire, B., Camonis, J., Slupphaus, G., Vigne, R., Benarous, R., and Sire, J. (1996). Human immunodeficiency virus type 1 Vpr protein binds to the uracil DNA glycosylase DNA repair enzyme. J. Virol. 70, 697-704.
7. Boyer, J. C., Bebenek, K., and Kunkel, T. A. (1992). Unequal human immunodeficiency virus type 1 reverse transcriptase error rates with RNA and DNA templates. Proc. Natl. Acad. Sci. USA 89, 6919-6923.
8. Cheng-Mayer, C., Shioda, T., and Levy, J. A. (1991). Host range, replicative, and cytopathic properties of human immunodeficiency virus type 1 are determined by very few amino acid changes in tat and gp120. J Virol. 65, 6931-6941.
9. Coffin, J. (1992). Genetic diversity and evolution of retroviruses. Curr. Top. Microbiol. Immunol. 176, 143-164.
10. Coffin, J. (1995). HIV population dynamics in vivo: Implications for genetic variation, pathogenesis, and therapy. Science 267, 483-489.
11. Coffin, J. M. (1990). Retroviridae and their replication. In "Virology" (B. N. Fields and D. M. Knipe, Eds.), pp. 1437-1500. Raven Press, New York.
12. Cohen, E. A., Dehni, G., Sodroski, J. G., and Haseltine, W. A. (1990). Human immunodeficiency virus vpr product is a virion-associated regulatory protein. J. Virol. 64, 3097-3099.
13. Cohen, E. A., Terwilliger, E. F., Jalinoos, Y., Proulx, J., Sodroski, J. G., and Haseltine, W. H. (1990). Identification of HIV-1 vpr product and function. J. Acquired Immune Defic. Syndr. 3, 11-18.
14. Dube, D. K., Sherman, M. P., Saksena, N. K., Bryz-Gornia, V., Mendelson, J., Love, J., Arnold, C. B., Spicer, T., Dube, S., Glaser, J. B., Williams, A. E., Nishimura, M., Jacobsen, S., Ferrer, J. F., del Pino, N., Quiruelas, S., and Poiesz, B. J. (1993). Genetic heterogeneity in human T-cell leukemia/lymphoma virus type II. J. Virol. 67, 1175-1184.
15. Gibbs, J. S., Lackner, A. A., Lang, S. M., Simon, M. A., Sehgal, P. K., Daniel, M. D., and Desrosiers, R. C. (1995). Progression to AIDS in the absence of a gene for vpr or vpx. J. Virol. 69, 2378-2383.
16. Hahn, B. H., Shaw, G. M., Taylor, M. E., Redfield, R. R., Markham, P. D., Salahuddin, S. Z., Wong-Staal, F., Gallo, R. C., Parks, E. S., and Parks, W. P. (1986). Genetic variation in HTLV-III/LAV over time in patients with AIDS or at risk for AIDS. Science 232, 1548-1553.
17. cdc2 activity. J. Virol. 69, 6705-6711.
18. Heinzinger, N. K., Bukrinsky, M. I., Haggerty, S. A., Ragland, A. M., Kewalramani, V., Lee, M.-A., Gendelman, H. E., Ratner, L., Stevenson, M., and Emerman, M. (1994). The Vpr protein of human immunodeficiency virus type 1 influences nuclear localization of viral nucleic acids in nondividing host cells. Proc. Natl. Acad. Sci. USA 91, 7311-7315.
19. Ho, D. D., Neumann, A. U., Perelson, A. S., Chen, W., Leonard, J. M., and Markowitz, M. (1995). Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature 373, 123-126.
20. Holland, J. J., De LaTorre, J. C., and Steinhauer, D. A. (1992). RNA virus populations as quasispecies. Curr. Top. Microbiol. Immunol. 176, 1-20.
21. Hu, W.-S., and Temin, H. M. (1990). Retroviral recombination and reverse transcription. Science 250, 1227-1233.
22. Hurley, J. M., Chervitz, S. A., Jarvis, T. C., Singer, B. S., and Gold, L. (1993). Assembly of the bacteriophage T4 replication machine requires the acidic carboxy terminus of gene 32 protein. J. Mol. Biol. 229, 398-418.
23. Ito, W., Ishiguro, H., and Kurosawa, Y. (1991). A general method for introducing a series of mutations into cloned DNA using the polymerase chain reaction. Gene 102, 67-70.
24. 2 + M phase of the cell cycle. J. Virol. 69, 6304-6313.
25. Kao, S.-Y., Calman, A. F., Luciw, P. A., and Peterlin, B. M. (1987). Anti-termination of transcription within the long terminal repeat of HIV-1 by tat gene product. Nature 330, 489-493.
26. Katz, R. A., and Skalka, A. M. (1990). Generation of diversity in retroviruses. Annu. Rev. Genet. 24, 409-445.
27. Kawai, S., and Nishizawa, M. (1984). New procedure for DNA transfection with polycation and dimethyl sulfoxide. Mol. Cell. Biol. 4, 1172-1174.
28. gag domain of human immunodeficiency virus type 1 is sufficient for the incorporation of Vpr into heterlogous viral particles. J. Virol. 69, 2759-2764.
29. Landau, N. R., and Littman, D. R. (1992). Packaging system for rapid production of murine leukemia virus vectors with variable tropism. J. Virol. 66, 5110-5113.
30. Lang, S. M., Weeger, M., Stahl-Hennig, C., Coulibaly, C., Hunsmann, G., Muller, J., Muller-Hermelink, H., Fuchs, D., Wachter, H., Daniel, M. M., Desrosiers, R. C., and Fleckenstein, B. (1993). Importance of vpr for infection of rhesus monkeys with simian immunodeficiency virus. J. Virol. 67, 902-912.
31. Lapadat-Tapolsky, M., De Rocquigny, H., Van Gent, D., Roques, B., Plasterk, R., and Darlix, J.-L. (1993). Interactions between HIV-1 nucleocapsid protein and viral DNA may have important functions in the viral life cycle. Nucleic Acids Res. 21, 831-839.
32. Levy, D. N., Fernandes, L. S., Williams, W. V., and Weiner, D. B. (1993). Induction of cell differentiation by human immunodeficiency virus 1 vpr. Cell 72, 541-550.
33. Levy, D. N., Refaeli, Y., MacGregor, R. R., and Weiner, D. B. (1994). Serum Vpr regulates productive infection and latency of human immunodeficiency virus type 1. Proc. Natl. Acad. Sci. USA 91, 10873-10877.
34. Levy, D. N., Refaeli, Y., and Weiner, D. B. (1995). Extracellular Vpr protein increases cellular permissiveness to human immunodeficiency virus replication and reactivates virus from latency. J. Virol. 69, 1243-1252.
35. Levy, J. A. (1993). Pathogenesis of human immunodeficiency virus infection. Microbiol. Rev. 57, 183-289.
36. gag is important for Vpr incorporation into human immunodeficiency virus type 1 particles. J. Virol. 69, 6873-6879.
37. Lu, Y.-L., Spearman, P., and Ratner, L. (1993). Human immunodeficiency virus type 1 viral protein R localization in infected cells and virions. J. Virol. 67, 6542-6550.
38. Mahalingam, S., Collman, R. G., Patel, M., Monken, C. E., and Srinivasan, A. (1995a). Functional analysis of HIV-1 Vpr: Identification of determinants essential for subcellular localization. Virology 212, 331-339.
39. Mahalingam, S., Khan, S. A., Jabbar, M. A., Monken, C. E., Collman, R. G., and Srinivasan, A. (1995b). Identification of residues in the N-terminal acidic domain of HIV-1 Vpr essential for virion incorporation. Virology 207, 297-302.
40. Mahalingam, S., Khan, S. A., Murali, R., Jabbar, M. A., Monken, C. E., Collman, R. G., and Srinivasan, A. (1995c). Mutagenesis of the putative alpha-helical domain of the Vpr protein of human immunodeficiency virus type 1: Effect on stability and virion incorporation. Proc. Natl. Acad. Sci. USA 92, 3794-3798.
41. Mansky, L. M. (1994). Retroviral-vector-mediated gene transfer. In "Cell and Tissue Culture: Laboratory Procedures" (J. B. Griffiths, A. Doyle, and D. G. Newell, Eds.), pp. 27B:5.1-27B5.10. Wiley, New York.
42. Mansky, L. M. (1996). Forward mutation rate of human immunodeficiency virus type 1 in a T-lymphoid cell line. AIDS Res. Hum. Retroviruses 12, 307-314.
43. Mansky, L. M., and Temin, H. M. (1994). Lower mutation rate of bovine leukemia virus relative to that of spleen necrosis virus. J. Virol. 68, 494-499.
44. Mansky, L. M., and Temin, H. M. (1995). Lower in vivo mutation rate of human immunodeficiency virus type 1 than that predicted from the fidelity of purified reverse transcriptase. J. Virol. 69, 5087-5094.
45. Mansky, L. M., Krueger, A. E., and Temin, H. M. (1995). The bovine leukemia virus encapsidation signal is discontinuous and extends into the 5′ end of the gag gene. J. Virol. 69, 3282-3289.
46. Martinez, M. A., Vartanian, J.-P., and Wain-Hobson, S. (1994). Hypermutagenesis of RNA using human immunodeficiency virus type 1 and biased dNTP concentrations. Proc. Natl. Acad. Sci. USA 91, 11787-11791.
47. Meyerhans, A., Vartanian, J.-P., Hultgren, C., Plikat, U., Karlsson, A., Wang, L., Eriksson, S., and Wain-Hobson, S. (1994). Restriction and enhancement of human immunodeficiency virus type 1 replication by modulation of intracellular deoxynucleoside triphosphate pools. J. Virol. 68, 535-540.
48. Mufti, S. (1979). Mutator effects of alleles of phage T4 gene 32, 41, 44, and 45 in the presence of an antimutator polymerase. Virology 94, 1-9.
49. Mufti, S. (1980). The effect on ultraviolet mutagenesis of genes 32, 41, 44, and 45 alleles of phage T4 in the presence of wild-type or antimutator DNA polymerase. Virology 105, 345-356.
50. Nakaya, T., Fujinaga, K., Kishi, M., Oka, S., Kurata, T., Jones, I. M., and Ikuta, K. (1994). Nonsense mutations in the vpr gene of HIV-1 during in vitro virus passage and in HIV-1 carrier-derived peripheral blood mononuclear cells. FEBS Lett. 354, 17-22.
51. Pathak, V. K., and Temin, H. M. (1990a). Broad spectrum of in vivo forward mutations, hypermutations, and mutational hotspots in a retroviral shuttle vector after a single replication cycle: Substitutions, frameshifts, and hypermutations. Proc. Natl. Acad. Sci. USA 87, 6019-6023.
52. Pathak, V. K., and Temin, H. M. (1990b). Broad spectrum of in vivo forward mutations, hypermutations, and mutational hotspots in a retroviral shuttle vector after a single replication cycle: Deletions and deletions with insertions. Proc. Natl. Acad. Sci. USA 87, 6024-6028.
53. Paxton, W., Connor, R. I., and Landau, N. R. (1993). Incorporation of Vpr into human immunodeficiency virus type 1 virions: Requirement for the p6 region of gag and mutational analysis. J. Virol. 67, 7229-7237.
54. Peterlin, B. M., Luciw, P. A., Barr, P. J., and Walker, M. D. (1986). Elevated levels of mRNA can account for the trans-activation of human immunodeficiency virus. Proc. Natl. Acad. Sci. USA 83, 9734-9738.
55. Planelles, V., Bachelerie, F., Jowett, J. B., Haislip, A., Xie, Y., Banooni, P., Masuda, T., and Chen, I. S. Y. (1995). Fate of the human immunodeficiency type 1 provirus in infected cells: A role for vpr. J. Virol. 69, 5883-5889.
56. Ratner, L., Philpott, T., and Trowbridge, D. (1991). Nucleotide sequence analysis of isolates of human T-lymphotropic virus type I of diverse geographical origins. AIDS Res. Hum. Retroviruses 7, 923-941.
57. Refaeli, Y., Levy, D. N., and Weiner, D. B. (1995). The glucocorticoid receptor type II complex is a target of the HIV-1 vpr gene product. Proc. Natl. Acad. Sci. USA 92, 3621-3625.
58. Rogel, M. E., Wu, L. I., and Emerman, M. (1995). The human immunodeficiency virus type 1 vpr gene prevents cell proliferation during chronic infection. J. Virol. 69, 882-888.
59. Sambrook, J., Fritsch, E. F., and Maniatis, T. (1989). "Molecular Cloning: A Laboratory Manual," 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
60. Smith, A. J., Cho, M.-L., Hammarskjold, M.-L., and Rekosh, D. (1990). Human immunodeficiency virus type 1 Pr55gag and Pr160gag-pol expressed from a simian virus 40 late replacement vector are efficiently processed and assembled into viruslike particles. J. Virol. 64, 2743-2750.
61. Starcich, B. R., Hahn, B. H., Shaw, G. M., McNeely, P. D., Modrow, S., Wolf, H., Parks, E. S., Parks, W. P., Josephs, S. F., Gallo, R. C., and Wong-Staal, F. (1986). Identification and characterization of conserved and variable regions in the envelope gene of HTLV III/LAV, the retrovirus of AIDS. Cell 45, 637-648.
62. Temin, H. M. (1961). Mixed infection with two types of Rous sarcoma virus. Virology 13, 158-163.
63. Temin, H. M. (1968). Studies on carcinogenesis by avian sarcoma viruses. VIII. Glycolysis and cell multiplication. Int. J. Cancer 3, 273-282.
64. Temin, H. M. (1993). Retrovirus variation and reverse transcription: Abnormal strand transfers result in retrovirus genetic variation. Proc. Natl. Acad. Sci. USA 90, 6900-6903.
65. Temin, H. M., and Mitzutani, S. (1970). RNA-dependent DNA polymerase in virions of Rous sarcoma virus. Nature (London) 226, 1211-1213.
66. Topal, M. D., and Sinha, N. K. (1983). Products of bacteriophage T4 genes 32 and 45 improve the accuracy of DNA replication in vitro. J. Biol. Chem. 258, 12274-12279.
67. Vartanian, J.-P., Meyerhans, A., Sala, M., and Wain-Hobson, S. (1994). G-A hypermutation of the human immunodeficiency virus type 1 genome: Evidence for dCTP pool imbalance during reverse transcription. Proc. Natl. Acad. Sci. USA 91, 3092-3096.
68. Watanabe, S. M., and Goodman, M. F. (1978). Mutator and antimutator phenotypes of suppressed amber mutants in genes 32, 41, 44, 45, and 62 in bacteriophage T4. J. Virol. 25, 73-77.
69. Wei, X., Ghosh, S. K., Taylor, M. E., Johnson, V. A., Emini, E. A., Deutsch, P., Lifson, J. D., Bonhoeffer, S., Nowak, M. A., Hahn, B. H., Saag, M. S., and Shaw, G. M. (1995). Viral dynamics in human immunodeficiency virus type 1 infection. Nature 373, 117-122.
70. Willems, L., Thienpont, E., Kerkhofs, P., Burny, A., Mammerickx, M., and Kettmann, R. (1993). Bovine leukemia virus, an animal model for the study of intrastrain variability. J. Virol. 67, 1086-1089.
71. Wong-Staal, F. (1990). Human immunodeficiency viruses and their replication. In "Virology" (B. N. Fields and D. M. Knipe, Eds.), pp. 1529-1543. Raven Press, New York.
72. Yao, X.-J., Subbramanian, R. A., Rougeau, N., Boisvert, F., Bergeron, D., and Cohen, E. A. (1995). Mutagenic analysis of human immunodeficiency virus type 1 Vpr: Role of a predicted N-terminal alpha-helical structure in Vpr nuclear localization and virion incorporation. J. Virol. 69, 7032-7044.
73. Zhang, J., and Temin, H. M. (1993). Rate and mechanisms of nonhomologous recombination during a single cycle of retroviral replication. Science 259, 234-238.
74. Zhao, L.-J., Mukherjee, S., and Narayan, O. (1994). Biochemical mechanism of HIV-1 Vpr function. J. Bol. Chem. 269, 15577-15582.